SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ishita Drugs & Inds. - Quaterly Results

02 Nov 2021 Evaluate
The sales for the September 2021 quarter moved down to Rs. 28.96 millions as compared to Rs. 37.96 millions during the year-ago period.The Net Profit of the company registered a slight decline of -7.95% to Rs. 1.39  millions from Rs. 1.51 millions.Operating Profit reported a sharp decline to 2.28 millions from 2.42 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 28.96 37.96 -23.71 57.85 61.00 -5.16 139.49 148.32 -5.95
Other Income 0.50 0.37 35.14 0.88 0.41 114.63 3.14 1.63 92.64
PBIDT 2.28 2.42 -5.79 4.45 4.13 7.75 12.32 9.26 33.05
Interest 0.12 0.06 100.00 0.17 0.12 41.67 0.32 0.35 -8.57
PBDT 2.16 2.36 -8.47 4.28 4.01 6.73 12.00 8.91 34.68
Depreciation 0.37 0.45 -17.78 0.74 0.89 -16.85 1.46 1.78 -17.98
PBT 1.79 1.91 -6.28 3.54 3.12 13.46 10.54 7.13 47.83
TAX 0.40 0.40 0.00 0.80 0.70 14.29 2.24 1.67 34.13
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.06 -0.09 -33.33
PAT 1.39 1.51 -7.95 2.74 2.42 13.22 8.30 5.46 52.01
Equity 29.90 29.90 0.00 29.90 29.90 0.00 29.90 29.90 0.00
PBIDTM(%) 7.87 6.38 23.49 7.69 6.77 13.61 8.83 6.24 41.47

Ishita Drugs & Inds. Share Price

77.00 0.94 (1.24%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×